Linkage Analysis of X-linked Cone-Rod Dystrophy: Localization to Xp11.4 and Definition of a Locus Distinct from RP2 and RP3  by Seymour, Albert B. et al.
Am. J. Hum. Genet. 62:122–129, 1998
122
Linkage Analysis of X-linked Cone-Rod Dystrophy: Localization to Xp11.4
and Definition of a Locus Distinct from RP2 and RP3
Albert B. Seymour,1,2,∗ Anita Dash-Modi,2 Jeffrey R. O’Connell,1 Maria Shaffer-Gordon,2
Tammy S. Mah,1,2 S. Tonya Stefko,2 Ramaiah Nagaraja,3 Jeremiah Brown,4 Alan E. Kimura,4
Robert E. Ferrell,1 and Michael B. Gorin1,2
1Department of Human Genetics, Graduate School of Public Health, and 2Department of Ophthalmology, School of Medicine, University of
Pittsburgh, Pittsburgh; 3Center for Genetics in Medicine, Washington University School of Medicine, St. Louis; and 4Department of
Ophthalmology, School of Medicine, University of Iowa, Iowa City
Summary
Progressive X-linked cone-rod dystrophy (COD1) is a
retinal disease affecting primarily the cone photorecep-
tors. The COD1 locus originally was localized, by the
study of three independent families, to a region between
Xp11.3 and Xp21.1, encompassing the retinitis pig-
mentosa (RP) 3 locus. We have refined the COD1 locus
to a limited region of Xp11.4, using two families re-
ported elsewhere and a new extended family. Genotype
analysis was performed by use of eight microsatellite
markers (tel-M6CA, DXS1068, DXS1058, DXS993,
DXS228, DXS1201, DXS1003, and DXS1055-cent),
spanning a distance of 20 cM. Nine-point linkage anal-
ysis, by use of the VITESSE program for X-linked dis-
orders, established a maximum LOD score (17.5) be-
tween markers DXS1058 and DXS993, spanning 4.0
cM. Two additional markers, DXS977 and DXS556,
which map between DXS1058 and DXS993, were used
to further narrow the critical region. The RP3 gene,
RPGR, was excluded on the basis of two obligate re-
combinants, observed in two independent families. In a
third family, linkage analysis did not exclude the RPGR
locus. The entire coding region of the RPGR gene from
two affected males from family 2 was sequenced and
was found to be normal. Haplotype analysis of two fam-
ily branches, containing three obligate recombinants,
two affected and one unaffected, defined the COD1 lo-
cus as distal to DXS993 and proximal to DXS556, a
distance of ∼1.0 Mb. This study excludes COD1 as an
allelic variant of RP3 and establishes a novel locus that
is sufficiently defined for positional cloning.
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Introduction
X-linked cone-rod dystrophy (COD1; OMIM 34020
[http://www3.ncbi.nlm.nih.gov:80/htbin-post/Omim/
dispmim?34020]) is a rare, progressive visual disease af-
fecting primarily the cone photoreceptors. Affected
males present with decreased visual acuity, myopia, pho-
tophobia, abnormal color vision, full peripheral visual
fields, and granularity of the macular retinal pigment
epithelium (RPE). Complete atrophy of the macular RPE
may develop late in life, accompanied by a progressive
decline in visual acuity (Pinckers and Timmerman 1981;
Pinckers et al. 1981; Jacobson et al. 1989). The degree
of rod-photoreceptor involvement can be variable, with
increasing degeneration as the disease progresses. Pho-
topic cone-mediated responses range from significantly
decreased to absent (Meire et al. 1994). Female carriers
have variable symptoms, ranging from asymptomatic to
photophobic with abnormal electroretinogram (ERG),
abnormal color vision, and abnormal visual evoked re-
sponse (Pinckers et al. 1981; Jacobson et al. 1989). Al-
though penetrance appears to be nearly 100%, there is
variable expressivity, with respect to age at onset and
severity of symptoms and findings (Hong et al. 1994).
COD1 originally was mapped to Xp11.3-21.1, in
1989 (Bartley et al. 1989). Additional evidence sup-
porting this map location was presented by Bergen et al.
(1993), Meire et al. (1994), and Hong et al. (1994).
These linkage studies, however, were unable to resolve
COD1 as an independent locus distinct from the retinitis
pigmentosa (RP) 2 and RP3 loci and supported the hy-
pothesis that COD1 could be an allelic variant of either
RP2 or RP3, on the basis of the chromosomal location
as well as clinical phenotypes. Allelic heterogeneity has
been well documented for other retinal dystrophies, such
as RP and Norrie disease (Chen et al. 1993; Shastry
1994; Gorin et al. 1995).
We have genotyped three extended families segregat-
ing COD1, using 11 polymorphic markers, spanning 20
cM, including both the RP2 and RP3 loci. Linkage anal-
ysis was performed with 8 markers, by use of the pro-
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Figure 1 Haplotype analysis of family 1, segregating COD1.
The at-risk haplotype is hatched, to clearly show recombinations. Car-
rier females are indicated by a black dot within a circle, and affected
males are indicated by blackened squares. Unblackened squares and
circles without a black dot denote unaffected males and noncarrier
females, respectively. A question mark (?) within a square indicates
that the affection status has not been established. An arrow indicates
the proband. The order of the markers is shown in the key to the left
of the figure and is consistent with that for families 2 and 3 (figs. 2
and 3, respectively). Alleles within parentheses were inferred, with the
exception of “(99)” in figures 2 and 3, which is an arbitrary number
inserted to establish phase.
gram VITESSE modified to handle X-linked pedigrees
(O’Connell and Weeks 1995). Recombinant mapping of
informative individuals was used to further define the
COD1 locus, with respect to RP2 and RP3.
Families and Methods
Families
Sixteen members of a five-generation family (family
1; fig. 1), 36 members of a six-generation family (family
2; fig. 2), and 35 members of a six-generation family
(family 3; fig. 3) were genotyped. The clinical descrip-
tions and diagnostic criteria for families 1 and 3 have
been described elsewhere (Jacobson et al. 1989; Hong
et al. 1994). Ophthalmic records of males (from family
3) who had not been evaluated by Jacobson et al. (1989)
were reviewed. Members of family 2 were characterized
by use of medical-chart review, as well as by detailed
interviews with family members, concerning visual prob-
lems associated with cone-rod dystrophy. The severity
of the phenotypes as well as the age at onset were var-
iable in all three families. The majority of the affected
males had lost central vision during their late teens or
early 20s. The proband (individual VI:3) and individuals
V:27 and VI:11 from family 2 were examined byM.B.G.
Members of family 3 were examined by J.B. and A.E.K.
Individual IV:16 from family 3 was examined at age 38
years. ERG findings revealed a normal scotopic cone
response; the B wave was 178/173 mV and 30/29.5 ms.
Diagnostic criteria for family 2 were as described by
Hong et al. (1994). For this study, the participation of
family members was approved by the University of Pitts-
burgh Biomedical Institutional Review Board, in accor-
dance with the guidelines of the Office for the Protection
from Research Risks, and informed patient consent was
obtained prior to participation.
PCR Analysis
Genomic DNAwas extracted from 10–20ml of whole
blood. Mononuclear cells were isolated by use of a den-
sity gradient, in accordance with themanufacturer’s con-
ditions (Hypaque; Pharmacia). Isolated cells were lysed
overnight in a 1.0% SDS, 0.5 mg proteinase K/ml so-
lution, at 50C. DNAwas precipitated after phenol-chlo-
roform purification by use of 0.33 vol 10 M ammonium
acetate and 2.5 vol 100% ethanol. MapPairs primers
(DXS993, DXS1003, DXS1068, DXS1058, DXS1201,
DXS228, and DXS1055) were purchased fromResearch
Genetics. M6CA primer sequences were 5′-TTC CTG
TGC ATG GGA ACC AC-3′ and 5′-GGA TGA ACA
ACC ACC CAA ATT-3′. DXS8025, DXS556, and
DXS977 are described in GDB (accession numbersGDB:
643168, GDB:197006, and GDB:377123, respectively),
and their map positions were estimated by use of SEG-
MAP (Magness et al. 1993), on the basis of data derived
from the Washington University Genome Center. The
forward primer for each set was end-labeled with T4
kinase (Gibco) and g-[32P]-ATP (New England Nuclear/
Dupont). The PCR conditions were 94C for 2 min,
followed by 35 cycles of 94C for 30 s, 55C for 1 min,
and 72C for 1 min, with 1 unit Taq polymerase in 25
mM TAPS (N-tris[hydroxymethyl]methyl-3-aminopro-
panesulfonic acid; pH 9.3), 1.5 mMMgCl2, 50mMKCl,
1 mM DTT, 0.2 mM dNTP, and 0.2 mM each primer,
Figure 2 Haplotype analysis of family 2, segregating COD1. Symbols are as defined in the legend to figure 1.
Figure 3 Haplotype analysis of family 3, segregating COD1. Symbols are as defined in the legend to figure 1.
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Table 1
Two-Point LOD Scores between the COD1 Locus and Markers Spanning
Xp11.3-p11.4
MARKER
LOD SCORE AT v 
.00 .05 .10 .20 .30 .40
M6CA 4.0458 3.76442 3.45707 2.76369 1.95841 1.03532
DXS1068 5.52884 12.08237 11.17213 8.8279 6.02898 2.87917
DXS1058 9.4829 8.70317 7.88757 6.13495 4.19265 2.05966
DXS993 12.58392 12.15392 11.16337 8.76569 5.97544 2.8354
DXS228 9.49005 9.59043 8.88967 7.05514 4.84172 2.31421
DXS1201 3.81624 8.33671 7.72942 6.07873 4.09985 1.89182
DXS1003 1.75344 11.28836 11.10132 9.33397 6.72528 3.52923
DXS1055 7.46604 3.26174 3.89578 3.54291 2.34304 .84782
in a final volume of 20 ml. PCR products were electro-
phoresed on a 6.0% polyacrylamide, 7 M urea dena-
turing sequencing gel and were dried and analyzed by
autoradiography. Product sizes were determined by com-
parison with an M13 sequencing ladder.
Linkage Analysis
Linkage analysis was performed by use of the linkage
program VITESSE, modified to handle X-linked data.
VITESSE, which uses a novel algorithm to perform rapid
multipoint likelihoods, was able to handle the complete
nine-point analysis without having to break the eight-
marker framework map into smaller sets. We thus were
able to extract maximum information on the position
of the trait locus. The frequency of the COD1 allele in
the general population was ∼.0001, with a penetrance
of .99. The order and distances of the markers used were
determined by use of the most recent genetic map of the
X chromosome (Nelson et al. 1995). The number of
alleles for each marker was as described in GDB. Because
allele frequencies were not available, alleles were as-
sumed to be at equal frequencies for all of the linkage
analyses.
Sequencing
Ten milliliters of whole blood was collected from in-
dividuals VI:3 and VI:6 from family 2. Peripheral lym-
phocytes were collected as described above. Whole RNA
was isolated by use of the RNAgents kit (Promega), in
accordance with the manufacturer’s protocol. First-
strand cDNA synthesis was performed by use of an
oligo(dT) primer, under standard reverse-transcrip-
tase–PCR conditions with 1 unit of reverse transcriptase
(Perkin-Elmer). The RP3 gene, RPGR (retinitis pigmen-
tosa GTPase regulator) (Meindl et al. 1996), was am-
plified in two overlapping segments, of 1.8 kb (5′) and
0.8 kb (3′), by use of the following primers: 5′
end—forward, 5′-ACC GTC CTC TAC AGC CTCC-3′,
and reverse, 5′-CTA CTT CCT CAT CTG AAA ATGC-
3′; and 3′ end—forward, 5′-CGC AGC CAG CTA CGA
CTA TC-3′, and reverse, 5′-TTA CAA TAC ACT TGG
TGA CTG TG-3′.
The samples were amplified for 35 cycles of 95C for
1 min, 60C for 1 min, and 72C for 1.5 min, followed
by extension at 72C for 10 min. PCR products were
subcloned into the PCR II vector, in accordance with the
manufacturer’s protocol (Invitrogen TA cloning kit). Se-
quencing was performed by use of M13 forward and
reverse primers and the following two internal primers
for the 1.8-kb fragment: 5′-CTG CCC TAA CTG AGG
ATG GAAG-3′ and 5′-GAG TCC CTT CTA TTG
GAGG-3′ (ALFexpress CY5 cycle sequencing kit; Phar-
macia). Sequence reactions were analyzed by use of the
ALFexpress automated sequencer.
Results
Linkage analysis was performed by use of the fol-
lowing markers: tel-M6CA–1.5 cM–DXS1068–
DXS1058–4.0 cM–DXS993–6.0 cM–DXS228–2.25
cM–DXS1201–2.25 cM–DXS1003–DXS1055. The
analysis was conducted by use of a model of X-linked
inheritance with a penetrance of .99 and a disease-allele
frequency of .0001. Nine-point linkage analysis calcu-
lated a maximum combined LOD score of 17.5 between
markers DXS1058 and DXS993, a distance estimated
to be !4 cM. Two-point linkage analysis, using identical
parameters, placed the disease locus closest to marker
DXS993, with a combined LOD score of 12.58 (recom-
bination fraction of ) (table 1).v  .00
Three recombinants, two affected and one unaffected,
were further genotyped by use of two markers between
DXS1058 and DXS993 (DXS977 and DXS556) to fur-
ther narrow the critical region of COD1 (fig. 2). Indi-
vidual IV:1 in family 1 defined the COD1 region prox-
imally, through a recombination between markers
DXS993 and DXS556, thus excluding RP3, which is
distal to marker DXS556 (Meindl et al. 1996). Individ-
ual IV:15 in family 3 defined the critical region distal-
ly, through a recombination between DXS993 and
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Figure 4 Map of the recombinations defining the critical COD1
region. The affected individuals define the critical region between
DXS556 and DXS228, on the basis of recombinations. The unaffected
individual narrows the critical region, on the basis of a recombination
between DXS993 and DXS556. The dashed lines depict the smallest
interval shared by affected individuals. The boldface lines represent
the affected haplotypes. The marker order for DXS977 and DXS556
was determined by use of Segmap (Magness et al. 1993). This map is
not drawn to scale.
DXS228, excluding RP2, which is proximal to DXS228
(Thiselton et al. 1996). Data on individual IV:16 in fam-
ily 3, an unaffected male (established by examination
and confirmed by ERG testing at age 38 years), were
used to define the critical region flanked by DXS993 and
DXS556, on the basis of the inclusion of the affected
haplotype at DXS993 and a recombination between
DXS993 and DXS556. These recombinants refined the
COD1 locus to a region that is flanked distally by
DXS556 and proximally by DXS993, an estimated phys-
ical distance of !1Mb. Although markers DXS1068 and
DXS1058 (distal) and DXS1055 and DXS1003 (prox-
imal) were !1.0 cM from each other, allelic association
was not determined, on the basis of the exclusion of
these regions by recombinations.
In all three families, RP2 was excluded by recombi-
nation events at markers distal to the RP2 locus. RP3
was excluded in families 1 and 3 on the basis of recom-
binations at markers proximal to the RP3 locus. In fam-
ily 2, RP3 could not be excluded by recombinations;
therefore, RPGR, the transcript of the RP3 gene, was
sequenced to screen for mutations. The entire coding
region was isolated from leukocyte mRNA of affected
individuals VI:3 and VI:6 from family 2 and was cloned
and sequenced as two overlapping DNA fragments of
1.8 kb (5′) and 0.8 kb (3′). No mutations were identified
when the coding region was compared with the pub-
lished sequence and a normal, control sequence. Se-
quencing was not performed on 5′ or 3′ UTRs or on
RPGR promoter sequences. On the basis of these data,
we have tentatively excluded the presence of the RP3
gene in this family. Therefore, COD1 is defined as a locus
distinct from RP2 and RP3.
Although families 1 and 3 were from New York and
Iowa, respectively, a similar haplotype was observed
among the affecteds from each family. Affected males in
these two pedigrees, with the exception of the two re-
combinants, have identical allele sizes for markers
DXS1068, DXS1058, DXS977, DXS556, and DXS993.
Discussion
COD1 has been hypothesized to be an allelic variant
of either RP2 or RP3. Using three large families segre-
gating COD1, we have defined the critical region to be
a locus distinct from those for RP2 and RP3. The RP2
locus has been mapped to a region that lies proximal to
marker DXS1201, in a 4–5-cM interval flanked by
markers DXS8083 and DXS6616 (Thiselton et al.
1996). Obligate recombinants proximal to this marker
were observed in all three families, thus excluding RP2
as the COD1 locus. The RP3 gene, RPGR, which was
identified recently, maps distal to marker DXS1068
(Meindl et al. 1996). In families 1 and 3, obligate re-
combinants proximal to DXS1068 excluded RP3 as the
COD1 locus. The coding region of RPGRwas sequenced
in family 2, and no mutations were identified, thus ten-
tatively excluding RP3. These data support our hypoth-
esis that COD1 is a unique locus flanked by RP2 and
RP3.
Linkage analyses of X-linked RP families have
mapped three loci (RP2, RP3, and RP15) to the short
arm of the X chromosome, with RP3 accounting for the
majority of cases (Chen et al. 1989; Musarella et al.
1990; Ott et al. 1990; Teague et al. 1994; Bergen et al.
1995; McGuire et al. 1995). Mutation analysis of RPGR
from affected males of X-linked RP families has deter-
mined that only 9.5% (7 of 74 families) are due to mu-
tations in this gene, suggesting that a novel locus could
be responsible for a subset of X-linked RP cases (Meindl
et al. 1996). The low frequency of RPGR mutations
identified in affected males and the mapping of COD1
as a distinct locus in proximity to RP2 and RP3 suggest
that some cases of X-linked RP could be allelic with
COD1. For family 1, we have previously reported clin-
ical heterogeneity, suggesting that identical mutations
within the same gene could lead to varying phenotypes
(Hong et al. 1994). Although most individuals with late-
stage cone-rod disease show considerable rod-photore-
ceptor involvement, this is possibly a secondary result
of the progressive degeneration of the cone photorecep-
tors. However, in family 1 there are individuals with a
disproportionate amount of rod-photoreceptor dysfunc-
tion at an early stage of the disease. None of the indi-
viduals in the families studied presentedwith phenotypes
that are distinctive for RP, such as peripheral pigmen-
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tation, night blindness, or peripheral vision loss. Phe-
notypic heterogeneity has been well documented for
other progressive retinal diseases with differing clinical
presentations. For example, mutations in the peripherin
gene have been described in families segregating either
autosomal dominant RP or macular dystrophy (Shastry
1994; Gorin et al. 1995).
Analysis of the most recent physical map of the X
chromosome suggests that the COD1 critical region lies
within a 1.0-Mb interval. This small region facilitates
both the construction of a physical contig spanning the
COD1 region and the use of positional cloning tech-
niques to identify and characterize the COD1 gene.
Haplotype analysis of the three families has provided
evidence supporting a possible founder effect. Families
1 and 3 are unrelated for at least six generations; how-
ever, the affected males share alleles at five markers cov-
ering a distance of 4.0 cM. Identification of the COD1
gene will resolve whether or not there is a possible foun-
der effect explaining the disease origin in these two
families.
We have defined COD1 as a locus distinct from both
RP2 and RP3 and have narrowed the critical region to
a distance suitable for the initiation of positional cloning
techniques. The identification and analysis of the COD1
gene may resolve the issues of allelic heterogeneity. In
addition, the characterization of the COD1 gene will
further our understanding of the biology pertaining to
degenerative eye diseases.
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